Table 2.
Potencies (EC50) and efficacies (Emax) of dopamine (DA) and L-SPD in stimulating D1 or D5 receptors to enhance cAMP formation in HEK cells expressing the human D1 or D5 receptor. Each value represents mean ± S.E.M. (n = 3–4).
| D1R | D5R | |||||
|---|---|---|---|---|---|---|
| Log[EC50(M)] | EC50 (μM) | Emax (% of 10−5 M DA response) [fold of basal] | Log[EC50(M)] | EC50 (μM) | Emax (% of 10−5 M DA response) [fold of basal] | |
| DA | −7.01 ± 0.20 | 0.098 ± 0.046 | 108.1 ± 9.7 [17.4] | −6.69 ± 0.12 | 0.20 ± 0.06 | 108.4 ± 5.3 [25.5] |
| L-SPD | −7.68 ± 0.12 | 0.021 ± 0.006 | 108.8 ± 4.0 [17.5] | −7.20 ± 0.28 | 0.063 ± 0.043 | 23.6 ± 2.0*** [6.5] |
p < 0.001 compared to DA using t-tests.